FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3136706118> ?p ?o ?g. }

• W3136706118 endingPage "2024" @default.
• W3136706118 startingPage "2016" @default.
• W3136706118 abstract "Aims As NEP degrades many substrates, the specific therapeutic mechanism of NEP inhibition with angiotensin receptor neprilysin inhibitor (ARNi) in heart failure with reduced ejection fraction (HFrEF) is not entirely evident. The aim of this study was to investigate the response of two substrates of NEP—the tachykinin and enkephalin systems—to the initiation of ARNi therapy in HFrEF. Methods and results Between 2016 and 2018, 141 consecutive patients with stable HFrEF [74 with initiation of ARNi and 67 controls on continuous angiotensin converting enzyme inhibitor (ACEi) or angiotensin receptor blocker (ARB) therapy] were prospectively enrolled. Plasma proenkephalin-A 119-159 (PENK) and pro-substance P (pro-SP) were serially determined. Proenkephalin-A 119-159 and pro-SP correlated strongly with each other (rs = 0.67, P < 0.001) and kidney function (rs = −0.66, P < 0.001 and rs = −0.54, P < 0.001) and modestly with NT-proBNP (rs = 0.32, P < 0.001 and rs = 0.24, P = 0.006, respectively). Concentrations of circulating PENK were slightly elevated after 1 and 2 year follow-up compared with baseline (BL) [BL median: 67.4 pmol/L (IQR: 57.3–89.8), 1 year: 83.5 pmol/L (IQR: 62.4–111.6), 2 years: 92.3 pmol/L (IQR: 63.1–101.9); BL vs. 1 year: P = 0.017 and BL vs. 2 years: P = 0.019] in the overall analysis, but lost significance at 2 year follow-up when assessed in paired subanalysis (P = 0.116). Plasma pro-SP levels remained comparable during the entire follow-up [BL median: 78.3 pmol/L (IQR: 67.9–90.6), 1 year: 75.9 pmol/L (IQR: 58.6–96.3), 2 years: 79.7 pmol/L (IQR: 59.9–105.3); P = ns for both timepoints]. Biomarker patterns of ARNi patients were independent from baseline therapy, that is, ACEi or ARB (P > 0.05 between groups). Conclusions Although enkephalins and SP are known substrates of NEP, NEP inhibition by ARNi does not clearly affect the circulating precursors PENK and pro-SP in HFrEF." @default.
• W3136706118 created "2021-03-29" @default.
• W3136706118 creator A5008120279 @default.
• W3136706118 creator A5015025542 @default.
• W3136706118 creator A5019910434 @default.
• W3136706118 creator A5028327090 @default.
• W3136706118 creator A5029331602 @default.
• W3136706118 creator A5030781152 @default.
• W3136706118 creator A5035540248 @default.
• W3136706118 creator A5047126901 @default.
• W3136706118 creator A5053758388 @default.
• W3136706118 creator A5068862747 @default.
• W3136706118 creator A5073438436 @default.
• W3136706118 date "2021-03-20" @default.
• W3136706118 modified "2023-10-10" @default.
• W3136706118 title "Neprilysin inhibition does not alter dynamic of proenkephalin‐A 119‐159 and pro‐substance P in heart failure" @default.
• W3136706118 cites W1948443536 @default.
• W3136706118 cites W1968308242 @default.
• W3136706118 cites W1969398085 @default.
• W3136706118 cites W1978083994 @default.
• W3136706118 cites W1988003878 @default.
• W3136706118 cites W2005663078 @default.
• W3136706118 cites W2006151566 @default.
• W3136706118 cites W2035023719 @default.
• W3136706118 cites W2039733070 @default.
• W3136706118 cites W2045844819 @default.
• W3136706118 cites W2063246991 @default.
• W3136706118 cites W2088087647 @default.
• W3136706118 cites W2097048083 @default.
• W3136706118 cites W2113698123 @default.
• W3136706118 cites W2114382165 @default.
• W3136706118 cites W2140597203 @default.
• W3136706118 cites W2140732936 @default.
• W3136706118 cites W2195052748 @default.
• W3136706118 cites W2222775601 @default.
• W3136706118 cites W2260980860 @default.
• W3136706118 cites W2412117386 @default.
• W3136706118 cites W2427094903 @default.
• W3136706118 cites W2475677373 @default.
• W3136706118 cites W2523054855 @default.
• W3136706118 cites W2562411701 @default.
• W3136706118 cites W2568312473 @default.
• W3136706118 cites W2602877283 @default.
• W3136706118 cites W2756899508 @default.
• W3136706118 cites W2804862454 @default.
• W3136706118 cites W2902578504 @default.
• W3136706118 cites W2903958160 @default.
• W3136706118 cites W2912800297 @default.
• W3136706118 cites W2918599246 @default.
• W3136706118 cites W3003995118 @default.
• W3136706118 cites W3006138287 @default.
• W3136706118 cites W3037761488 @default.
• W3136706118 cites W3088122434 @default.
• W3136706118 cites W4238907867 @default.
• W3136706118 doi "https://doi.org/10.1002/ehf2.13278" @default.
• W3136706118 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8120349" @default.
• W3136706118 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33742565" @default.
• W3136706118 hasPublicationYear "2021" @default.
• W3136706118 type Work @default.
• W3136706118 sameAs 3136706118 @default.
• W3136706118 citedByCount "2" @default.
• W3136706118 countsByYear W31367061182023 @default.
• W3136706118 crossrefType "journal-article" @default.
• W3136706118 hasAuthorship W3136706118A5008120279 @default.
• W3136706118 hasAuthorship W3136706118A5015025542 @default.
• W3136706118 hasAuthorship W3136706118A5019910434 @default.
• W3136706118 hasAuthorship W3136706118A5028327090 @default.
• W3136706118 hasAuthorship W3136706118A5029331602 @default.
• W3136706118 hasAuthorship W3136706118A5030781152 @default.
• W3136706118 hasAuthorship W3136706118A5035540248 @default.
• W3136706118 hasAuthorship W3136706118A5047126901 @default.
• W3136706118 hasAuthorship W3136706118A5053758388 @default.
• W3136706118 hasAuthorship W3136706118A5068862747 @default.
• W3136706118 hasAuthorship W3136706118A5073438436 @default.
• W3136706118 hasBestOaLocation W31367061181 @default.
• W3136706118 hasConcept C104826730 @default.
• W3136706118 hasConcept C126322002 @default.
• W3136706118 hasConcept C134018914 @default.
• W3136706118 hasConcept C159641895 @default.
• W3136706118 hasConcept C170493617 @default.
• W3136706118 hasConcept C181199279 @default.
• W3136706118 hasConcept C185592680 @default.
• W3136706118 hasConcept C2776754050 @default.
• W3136706118 hasConcept C2777515746 @default.
• W3136706118 hasConcept C2777803847 @default.
• W3136706118 hasConcept C2778198053 @default.
• W3136706118 hasConcept C2781063702 @default.
• W3136706118 hasConcept C2781372283 @default.
• W3136706118 hasConcept C55493867 @default.
• W3136706118 hasConcept C71924100 @default.
• W3136706118 hasConcept C78085059 @default.
• W3136706118 hasConceptScore W3136706118C104826730 @default.
• W3136706118 hasConceptScore W3136706118C126322002 @default.
• W3136706118 hasConceptScore W3136706118C134018914 @default.
• W3136706118 hasConceptScore W3136706118C159641895 @default.
• W3136706118 hasConceptScore W3136706118C170493617 @default.
• W3136706118 hasConceptScore W3136706118C181199279 @default.
• W3136706118 hasConceptScore W3136706118C185592680 @default.

• next